HomeSABS • NASDAQ
add
SAB Biotherapeutics Inc
Previous close
$1.49
Day range
$1.44 - $1.75
Year range
$1.00 - $5.01
Market cap
16.26M USD
Avg Volume
27.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 114.70K | -62.40% |
Operating expense | 2.47M | -83.39% |
Net income | -11.39M | 50.15% |
Net profit margin | -9.93K | -32.57% |
Earnings per share | -0.98 | 84.65% |
EBITDA | -9.24M | 48.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.76M | -63.30% |
Total assets | 44.20M | -47.35% |
Total liabilities | 18.23M | -31.59% |
Total equity | 25.97M | — |
Shares outstanding | 9.29M | — |
Price to book | 0.53 | — |
Return on assets | -51.07% | — |
Return on capital | -69.45% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -11.39M | 50.15% |
Cash from operations | -9.53M | 29.11% |
Cash from investing | 9.33M | 13,849.21% |
Cash from financing | 216.96K | -99.68% |
Net change in cash | -273.21K | -100.50% |
Free cash flow | -6.91M | 37.82% |
About
Founded
2014
Headquarters
Website
Employees
63
